These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Benemid (p-di-n-propylsulfamyl)-benzoic acid) as uricosuric agent in chronic gouty arthritis. GUTMAN AB; YU TF Trans Assoc Am Physicians; 1951; 64():279-88. PubMed ID: 14884260 [No Abstract] [Full Text] [Related]
4. THE TREATMENT OF GOUT. TREADWELL B N Z Med J; 1964 Sep; 63():567-74. PubMed ID: 14210072 [No Abstract] [Full Text] [Related]
5. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents]. Delbarre F; Saporta L; de Géry A; Jabre E Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852 [No Abstract] [Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic interaction between allopurinol and probenecid in patients with gout. Stocker SL; Graham GG; McLachlan AJ; Williams KM; Day RO J Rheumatol; 2011 May; 38(5):904-10. PubMed ID: 21285173 [TBL] [Abstract][Full Text] [Related]
7. Treatment of gout. Muñez-Sanz A; Garcia-Puig J; Mateos F N Engl J Med; 1981 Jul; 305(1):49-50. PubMed ID: 7231517 [No Abstract] [Full Text] [Related]
9. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient. Decaux G; Soupart A; Musch W; Hannotier P; Prospert F Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074 [TBL] [Abstract][Full Text] [Related]
10. The search for uricosuric agents suited to the management of tophaceous gout. GUTMAN AB N Y State J Med; 1963 Feb; 63():576-85. PubMed ID: 13951446 [No Abstract] [Full Text] [Related]